Editas proposes $50M follow-on

Gene editing company Editas Medicine Inc. (NASDAQ:EDIT) proposed to raise $50 million in a follow-on underwritten by Morgan Stanley. Editas, which proposed the offering after market close Tuesday, was off $0.47 to $27.29 on the day...